Exclusion Criteria:~* Inability or unwillingness to give written informed consent~* History of stroke, severe
brain trauma, toxic drug exposure~* Neurological examination which indicate to Parkinson-Plus syndrome (i.e.,
pyramidal, cerebellar and autonomic dysfunction findings and gaze paralysis) for PD~* Uncontrolled Type 1 or
type 2 diabetes~* Diarrhea (defined as more than 2 stool per day) within 7 days before enrolment~* Chronic
kidney disease with an estimated glomerular filtration rate <60 ml/min/1.73m2~* Significant cardiovascular
co-morbidity (i.e. heart failure, documented coronary artery disease, valvular heart disease)~* Patients with
active bronchial asthma~* Patients with phenylketonuria (contraindicated for NAC)~* Patients with histamine
intolerance~* Clinically significant TSH level outside the normal range (0.04-6 mU/L)~* Known allergy for
substances used in the study~* Concomitant medication use: Self-administration of dietary supplements such as
any vitamins, omega-3 products, or plant stanol/sterol products within 1 month; Use of an antimicrobial agent
in the 4 weeks preceding randomization~* Active smokers consuming >10 cigarettes/day~* Alcohol consumption over
192 grams for men and 128 grams for women per week~* Patients considered as inappropriate for this study for
any reason (patients unable to undergo MRI study, noncompliance etc.)~* Active participation in another
clinical study
